共 50 条
- [41] Inhibition of radiologically detectable structural joint destruction in patients with rheumatoid arthritis over 5 years under treatment with Adalimumab (Humira®) plus Methotrexate (MTX) ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 35 - 35
- [42] LIGHT IMMUNOHISTOCHEMICAL AND ELECTRON-MICROSCOPIC STUDY OF LIVER BIOPSIES FROM PATIENTS RECEIVING LONG-TERM METHOTREXATE (MTX) FOR TREATMENT OF RHEUMATOID-ARTHRITIS ANATOMICAL RECORD, 1987, 218 (01): : A144 - A144
- [43] METHOTREXATE IN OLDER PATIENTS WITH RHEUMATOID-ARTHRITIS BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 (12): : 860 - 860
- [46] IMMUNE CHARACTERIZATION OF CUTANEOUS VASCULITIS DEVELOPED IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA) TREATED OR NOT WITH METHOTREXATE (MTX) ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S338 - S338
- [47] PROSPECTIVE-STUDY OF HEPATOTOXICITY IN PATIENTS RECEIVING METHOTREXATE FOR RHEUMATOID-ARTHRITIS - AN UPDATE ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S77 - S77
- [48] SELECTIVE VS UNSELECTIVE LIVER BIOPSIES IN METHOTREXATE (MTX)-TREATED RHEUMATOID-ARTHRITIS (RA) PATIENTS ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S64 - S64
- [49] EFFECTS OF LOW-DOSE METHOTREXATE (MTX) TREATMENT ON BONE-MINERAL DENSITY (BMD) IN PATIENTS WITH RHEUMATOID-ARTHRITIS ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 954 - 954